Sign In
Gilead SciencesIn the news
When you get LEN for the first time, one LEN dose consists of two injections and four pills. Photo: Mia Malan
HIV AIDS

Would homegrown LEN cost more? Why SA should still make the HIV prevention jab

South Africa aims to manufacture the revolutionary six-monthly HIV prevention injection lenacapavir locally. Experts weigh the need for rapid, affordable access against building…

  • Vinodh Aroon Edward
9 min read
HIV PREVENTION
Video

SA and Zambia’s HIV shot dilemma: Demand versus supply

South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early…

  • Ida Jooste
11 min read
HIV PREVENTION

#Aids2026: Bhekisisa analysed SA’s first LEN roll-out data. Here's what it found

South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of the continent's roughly 60,000 users are in the…

  • Mia Malan
  • Linda Pretorius
  • Karen Harkema
11 min read
HIV PREVENTION

#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters

For the first time, Merck has granted generic manufacturers, including three African companies, permission to produce an investigational monthly HIV prevention pill, alimatravir,…

  • Mia Malan
  • Linda Pretorius
  • Karen Harkema
9 min read